- Home
- IRBT vs TCRX Comparison
IRBT vs TCRX Comparison
Compare IRBT & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- TCRX
- Stock Information
- Founded
- IRBT 1990
- TCRX 2018
- Country
- IRBT United States
- TCRX United States
- Employees
- IRBT N/A
- TCRX N/A
- Industry
- IRBT Consumer Electronics/Appliances
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- IRBT Consumer Discretionary
- TCRX Health Care
- Exchange
- IRBT Nasdaq
- TCRX Nasdaq
- Market Cap
- IRBT 99.8M
- TCRX 100.7M
- IPO Year
- IRBT N/A
- TCRX 2021
- Fundamental
- Price
- IRBT $3.17
- TCRX $1.44
- Analyst Decision
- IRBT Hold
- TCRX Strong Buy
- Analyst Count
- IRBT 1
- TCRX 6
- Target Price
- IRBT N/A
- TCRX $9.50
- AVG Volume (30 Days)
- IRBT 3.8M
- TCRX 470.2K
- Earning Date
- IRBT 08-05-2025
- TCRX 08-11-2025
- Dividend Yield
- IRBT N/A
- TCRX N/A
- EPS Growth
- IRBT N/A
- TCRX N/A
- EPS
- IRBT N/A
- TCRX N/A
- Revenue
- IRBT $633,404,000.00
- TCRX $4,421,000.00
- Revenue This Year
- IRBT $3.23
- TCRX $159.20
- Revenue Next Year
- IRBT $28.90
- TCRX N/A
- P/E Ratio
- IRBT N/A
- TCRX N/A
- Revenue Growth
- IRBT N/A
- TCRX N/A
- 52 Week Low
- IRBT $1.76
- TCRX $1.02
- 52 Week High
- IRBT $13.45
- TCRX $7.89
- Technical
- Relative Strength Index (RSI)
- IRBT 48.39
- TCRX 44.26
- Support Level
- IRBT $3.03
- TCRX $1.44
- Resistance Level
- IRBT $3.60
- TCRX $1.61
- Average True Range (ATR)
- IRBT 0.36
- TCRX 0.16
- MACD
- IRBT -0.07
- TCRX -0.02
- Stochastic Oscillator
- IRBT 15.88
- TCRX 10.44
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.